Lymphocytes delay kinetics of HSV-1 reactivation from in vitro explants of latent infected trigeminal ganglia

Journal of Neuroimmunology

Volumn 95, Issue 1-2, 1999, Pages 126-135

  Noisakran, Sansanee ^a   Carr, Daniel J J ^a  

^a Neurology Department   (United States)

Author keywords

HSV 1; Interleukin 6; Neuroimmunology; Splenocytes

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 6; NEUTRALIZING ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; EXPLANT; HERPES SIMPLEX VIRUS 1; IMMUNE RESPONSE; IN VITRO STUDY; LYMPHOCYTE; MOUSE; NEUROIMMUNOLOGY; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TRIGEMINUS GANGLION; VIRUS CULTURE;

ANIMALS; ANTIBODIES; ANTIGENS, CD4; ANTIGENS, CD8; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CERCOPITHECUS AETHIOPS; FEMALE; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-2; INTERLEUKIN-6; KINETICS; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS; RECURRENCE; SPLEEN; TRIGEMINAL GANGLION; VERO CELLS;

EID: 0033104107     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00008-9     Document Type: Article

References (50)

1. Akira S., Kishimoto T. IL-6 and NF-IL6 in acute-phase response and viral infection. Immunol. Rev. 127:1992;25-50.
2. Anderson R.E., Sprent J., Miller J.F.A.P. Radiosensitivity of T and B lymphocytes: I. Effect of irradiation on cell migration. Eur. J. Immunol. 4:1974;199-203.
3. Berkowitz C., Becker Y. Recombinant interleukin-1α, interleukin-2, and M-CSF-1 enhance the survival of newborn C57BL/6 mice inoculated intraperitoneally with a lethal dose of herpes simplex virus-1. Arch. Virol. 124:1992;83-93.
4. Anderson R.E., Warner N.L. Ionizing radiation and the immune response. Adv. Immunol. 24:1976;215-335.
5. Bonneau R.H., Jennings S.R. Modulation of acute and latent herpes simplex virus infection in C57BL/6 mice by adoptive transfer of immune lymphocytes with cytolytic activity. J. Virol. 63:1989;1480-1484.
6. Bouley D.M., Kanangat S., Wire W., Rouse B.T. Characterization of herpes simplex virus type-1 infection and herpetic stromal keratitis development in IFN-γ knockout mice. J. Immunol. 155:1995;3964-3971.
7. Cantin E.M., Hinton D.R., Chen J., Openshaw H. Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1. J. Virol. 69:1995;4898-4905.
8. Carr D.J.J., Mayo S., Gebhardt B.M., Porter J.P. Central α-adrenergic involvement in morphine-mediated suppression of splenic natural killer activity. J. Neuroimmunol. 53:1994;53-63.
9. Carr D.J.J., Noisakran S., Halford W.P., Lukacs N., Asensio V., Campbell I.L. Cytokine and chemokine production in HSV-1 latently infected trigeminal ganglion cell cultures: effects of hyperthermic stress. J. Neuroimmunol. 85:1998;111-121.
10. Chen S.H., Oakes J.E., Lausch R.N. Synergistic anti-HSV effect of tumor necrosis factor alpha and interferon gamma in human corneal fibroblasts is associated with interferon beta induction. Antiviral Res. 22:1993;15-29.
11. Clouse K.A., Bach F.H., Orosz C.G. Detection of HSV-1-induced lymphokine production in human cells by a direct indicator cell addition assay. J. Immunol. 132:1984;2961-2967.
12. Cook M.L., Stevens J.G. Pathogenesis of herpetic neuritis and ganglionitis in mice: evidence for intra-axonal transport of infection. Infect. Immun. 7:1973;272-288.
13. Engler H., Zawatzky R., Goldbach A., Schroder C.H., Weyand C., Hammerling G., Kirchner H. Experimental infection of inbred mice with herpes simplex virus: II. Interferon production and activation of natural killer cells in the peritoneal exudate. J. Gen. Virol. 55:1981;25-30.
14. Feduchi E., Alonso M.A., Carrasco L. Human gamma interferon and tumor necrosis factor exert a synergistic blockade on the replication of herpes simplex virus. J. Virol. 63:1989;1354-1359.
15. Greene A.L., Makrigiannis A.P., Fitzpatrick L., Hoskin D.W. Anti-CD3-activated killer T cells: interleukin-6 modulates the induction of major histocompatibility complex-unrestricted cytotoxicity and the expression of genes coding for cytotoxic effector molecules. J. Interferon Cytokine Res. 17:1997;727-737.
16. Halford W.P., Gebhardt B.M., Carr D.J.J. Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type 1. J. Immunol. 157:1996;3542-3549.
17. Halford W.P., Gebhardt B.M., Carr D.J.J. Acyclovir blocks cytokine gene expression in trigeminal ganglia latently infected with herpes simplex virus type 1. Virology. 238:1997;53-63.
18. Halford W.P., Veress L.A., Gehbardt B.M., Carr D.J.J. Innate and acquired immunity to herpes simplex virus type 1. Virology. 236:1997;328-337.
19. Hendricks R.L., Tumpey T.M., Finnegan A. IFN-γ and IL-2 are protective in the skin but pathologic in the corneas of HSV-1-infected mice. J. Immunol. 149:1992;3023-3028.
20. Hendricks R.L., Weber P.C., Taylor J.L., Koumbis A., Tumpey T.M., Glorioso J.C. Endogenously produced interferon α protects mice from herpes simplex virus type 1 corneal disease. J. Gen. Virol. 72:1991;1601-1610.
21. Hill A., Jugovic P., York I., Russ G., Bennink J., Yewdell J., Ploegh H., Johnson D. Herpes simplex virus turns off the TAP to evade host immunity. Nature. 375:1995;411-415.
22. Igietseme J.U., Streilein J.W., Miranda F., Feinerman S.J., Atherton S.S. Mechanisms of protection against herpes simplex virus type 1-induced retinal necrosis by in vitro-activated T lymphocytes. J. Virol. 65:1991;763-768.
23. Ikemoto K., Pollard R.B., Fukumoto T., Morimatsu M., Suzuki F. Small amounts of exogenous IL-4 increase the severity of encephalitis induced in mice by the intranasal infection of herpes simplex virus type 1. J. Immunol. 155:1995;1326-1333.
24. Jerome K.R., Tait J.F., Koelle D.M., Corey L. Herpes simplex virus type 1 renders infected cells resistant to cytotoxic T-lymphocyte-induced reactivation. J. Virol. 72:1998;436-441.
25. Kanangat S., Babu J.S., Knipe D.M., Rouse B.T. HSV-1-mediated modulation of cytokine gene expression in a permissive cell line: selective upregulation of IL-6 gene expression. Virology. 210:1996;30-295.
26. Kishimoto T., Akira S., Narazaki M., Taga T. Interleukin-6 family of cytokines and gp130. Blood. 86:1995;1243-1254.
27. Kosz-Vnenchak M., Jacobson J., Coen D.M., Knipe D.M. Evidence for a novel regulatory pathway for herpes simplex virus gene expression in trigeminal ganglion neurons. J. Virol. 67:1993;5383-5393.
28. Kriesel J.D., Gebhardt B.M., Hill J.M., Maulden S.A., Hwang I.P., Clinch T.E., Cao X., Spruance S.L., Araneo B.A. Anti-interleukin-6 antibodies inhibit herpes simplex virus reactivation. J. Infect. Dis. 175:1997;821-827.
29. Kriesel J.D., Ricigliano J., Spruance S.L., Garza H.H., Hill J.H. Neuronal reactivation of herpes simplex virus involves intueleukin-6. J. Neurovirol. 3:1998;441-448.
30. Leary K., Connor J.R., Morahan P.S. Comparison of herpes simplex virus type 1 DNA replication and virus production in murine bone marrow-derived and resident peritoneal macrophages. J. Gen. Virol. 66:1985;1123-1129.
31. Linnavuori K., Hovi T. Restricted replication of herpes simplex virus in human monocyte cultures: role of interferon. Virology. 130:1983;1-9.
32. Liu T., Tang Q., Hendricks R.L. Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection. J. Virol. 70:1996;264-271.
33. Lowenthal J.W., Harris A.W. Activation of mouse lymphocytes inhibits induction of rapid cell death by x-irradiation. J. Immunol. 135:1985;1119-1125.
34. + T lymphocytes. J. Immunol. 155:1995;259-265.
35. Mittnacht S., Straub P., Kirchner H., Jacobsen H. Interferon treatment inhibits onset of herpes simplex virus immediate-early transcription. Virology. 164:1988;201-210.
36. Morrison L.A., Knipe D.M. Contributions of antibody and T cells subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1. Virology. 239:1997;315-326.
37. Munoz A., Carrasco L. Formation of non-infective herpesvirus particles in cultured cells treated with human interferon. J. Gen. Virol. 65:1984;1069-1078.
38. Noisakran S., Halford W.P., Veress L., Carr D.J.J. The role of the hypothalamic pituitary adrenal axis and IL-6 in stress-induced reactivation of latent HSV-1. J. Immunol. 160:1998;5441-5447.
39. Pereira R.A., Tscharke D.C., Simmons A. Upregulation of class I major histocompatibility complex gene expression in primary sensory neurons, satellite cells, and schwann cells of mice in response to acute but not latent herpes simplex virus infection in vivo. J. Exp. Med. 180:1994;841-850.
40. Reitnauer P.J., Brown L.R., Hank J.A., Sondel P.M. Proliferative response to a nonspecific factor produced by irradiated stimulating cells can simulate antigen-specific secondary responses in the primed lymphocyte test. J. Immunol. 131:1983;165-170.
41. Sawtell N.M., Thompson R.L. Rapid in vivo reactivation of herpes simplex virus type 1 in latently infected murine ganglionic neurons after transient hyperthermia. J. Virol. 66:1992;2150-2156.
42. Shimeld C., Whiteland J.L., Nicholls S.M., Grinfeld E., Easty D.L., Gao H., Hill T.J. Immune cell infiltration and persistence in the mouse trigeminal ganglion after infection of the cornea with herpes simplex virus type 1. J. Neuroimmunol. 61:1995;7-16.
43. Shimeld C., Whiteland J.L., Williams N.A., Easty D.L., Hill T.J. Reactivation of herpes simplex virus type 1 in the mouse trigeminal ganglion: an in vivo study of virus antigen and immune cell infiltration. J. Gen. Virol. 77:1996;2583-2590.
44. Simmons A., Tscharke D.C. Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: implications for the fate of virally infected neurons. J. Exp. Med. 175:1992;1337-1344.
45. Straub P., Domke I., Kirchner H., Jacobsen H., Panet A. Synthesis of herpes simplex virus proteins and nucleic acids in interferon-treated macrophages. Virology. 150:1986;411-418.
46. Tang Q., Chen W., Hendricks R.L. Proinflammatory functions of IL-2 in herpes simplex virus corneal infection. J. Immunol. 158:1997;1275-1283.
47. Tumpey T.M., Chen S.H., Oakes J.E., Lausch R.N. Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea. J. Virol. 70:1996;898-904.
48. Walev I., Podlech J., Falke D. Enhancement by TNF-α of reactivation and replication of latent herpes simplex virus from trigeminal ganglia of mice. Arch. Virol. 140:1995;987-992.
49. Wong G.H.W., Goeddel D.V. Tumour necrosis factor α and β inhibit virus replication and synergize with interferons. Nature. 323:1986;819-822.
50. Yamada M., Arao Y., Hatano A., Uno F., Nii S. Effect of recombinant mouse interferon-β on acute and latent herpes simplex infection in mice. Arch. Virol. 99:1988;101-109.